Harvard Gastroenterology 2024 (Videos)

Description

The Comprehensive 2024 Gastroenterology Update

Date : June 10 – 13, 2024

Overview
This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.
Practical, Results-Driven Education
Highlights of the 2024 program include:

Updated guidelines for the use of biologics in IBD
Therapeutic drug monitoring in IBD treatment
Management of the older adult with IBD
Updated guidelines for treatment of C. difficile infection
Managing GI complications of immunotherapy
Improved management of IBS
Tips to managing fecal incontinence
Management of refractory GERD
Expanded genetic testing options to diagnose hereditary GI cancer syndromes
Management of fatty liver disease in 2024
How to diagnose and manage cirrhosis
How to improve your adenoma detection rate (ADR)
Steps to ensure delivery of high-quality colonoscopic care
Techniques to effectively control acute GI bleeding
Endoscopic management of obesity
When FMT is indicated for treatment
Impact of COVID on the GI tract
New strategies to treat common GI problems
A comprehensive update of national guidelines

As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Education to Optimize Your Patient Outcomes
The evidence-based recommendations provided in this program cover:

IBD
GI Complications of Immunotherapy
Microscopic Colitis
Fatty Liver
Barrett’s Esophagus
Eosinophilic Esophagitis
C. difficile Colitis
Alcohol-Related Liver Disease
Autoimmune Hepatitis
IBS
Refractory GERD
Acute Pancreatitis
Chronic Pancreatitis
Celiac Disease
GI Bleeding
High Risk for Colorectal Cancer

Recent Advances and Innovations
Clinicians can rely on this program for education on:

Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
Managing refractory pouchitis
GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
The stool microbiome: understanding the science behind clinical applications
Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
Endoscopic approaches to managing obesity

This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.

Who Should Attend

Gastroenterologists
Internists
Surgeons
Nurse Practitioners
Physician Assistants